Signals, Powered By EquityPandit
Dr Reddy’s Laboratories Ltd and Turkey based TR-Pharma has entered into a strategic collaboration agreement involving three biosimilar products.
The company has said in a statement that “We have entered into a strategic collaboration agreement with Turkey-based TR-Pharm involving 3 biosimilar products. These products will be registered and subsequently commercialised as a part of this agreement by TR-Pharm in Turkey.”
It further said that TR-Pharma will also be manufacturing the drug substance and drug product upon completion of its facility investment.
